Ligand Pharmaceuticals Incorporated (LGND) financial statements (2020 and earlier)

Company profile

Business Address 3911 SORRENTO VALLEY BLVD
SAN DIEGO, CA 92121
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1,01271820214120016
Cash and cash equivalents7211721199712
Short-term investments9406011811221034
Restricted cash and investments1     
Receivables4256261562
Inventory, net of allowances, customer advances and progress billings774221
Inventory774221
Prepaid expense     1
Derivative instruments and hedges, assets 23    
Other current assets5202221
Other undisclosed current assets58464354
Total current assets:1,12487123716321525
Noncurrent Assets
Operating lease, right-of-use asset10
Property, plant and equipment754201
Long-term investments and receivables  6830 
Long-term investments  6830 
Intangible assets, net (including goodwill)3063063152776165
Goodwill958786721212
Intangible assets, net (excluding goodwill)2102202292054853
Restricted cash and investments     1
Deferred income tax assets26
Other noncurrent assets205200
Deferred tax assets, net  124189 
Other undisclosed noncurrent assets207810426912
Total noncurrent assets:37139043443928880
TOTAL ASSETS:1,4951,261671602503105
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1223109911
Accounts payable242344
Accrued liabilities10197655
Employee-related liabilities     2
Deferred revenue2
Debt1262252132029
Derivative instruments and hedges, liabilities 23    
Deferred revenue and credits   0
Contract with customer, liability3
Other liabilities    0 
Other undisclosed current liabilities1655118
Total current liabilities:178223922722329
Noncurrent Liabilities
Long-term debt and lease obligation649610    
Long-term debt, excluding current maturities639610    
Operating lease, liability10
Liabilities, other than long-term debt5514104
Deferred revenue and credits4  2
Deferred tax liabilities, net    1
Deferred income tax liabilities33
Other liabilities2211101
Other undisclosed noncurrent liabilities6793322
Total noncurrent liabilities:711618144326
Total liabilities:72870025223122655
Stockholders' equity
Stockholders' equity attributable to parent76756140034123750
Common stock000000
Additional paid in capital367791798770662718
Accumulated other comprehensive income (loss)(0)(1)2353
Retained earnings (accumulated deficit)400(229)(401)(431)(429)(671)
Total stockholders' equity:76756140034123750
Other undisclosed liabilities and equity  193040 
TOTAL LIABILITIES AND EQUITY:1,4951,261671602503105

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues1202511411097249
Revenue, net111826646
Cost of revenue
(Cost of Goods and Services Sold)
(17)(6)(12)(6)(1)(6)
Gross profit:1032451291037143
Operating expenses(126)(88)(73)(65)(45)(52)
Other undisclosed operating income8306126124
Operating income:80716468442715
Nonoperating income (expense)(10)10(11)(36)8(6)
Investment income, nonoperating3114  28 
Other nonoperating income (expense)(6)(6)532(0)
Interest and debt expense(36)(48)   (2)
Other undisclosed income from continuing operations before equity method investments, income taxes3648   2
Income from continuing operations before equity method investments, income taxes:797173578359
Income from equity method investments3     
Income from continuing operations before income taxes:800173578359
Income tax expense (benefit)(167)(30)(45)(10)192(0)
Income (loss) from continuing operations:63214313(2)2279
Income from discontinued operations   1  
Income (loss) before gain (loss) on sale of properties:63214313(2)2279
Other undisclosed net loss(3)     
Net income (loss):62914313(2)2279
Net income attributable to noncontrolling interest    2 
Other undisclosed net income attributable to parent     3
Net income (loss) available to common stockholders, diluted:62914313(2)23011

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income (loss):62914313(2)2279
Other comprehensive income (loss) 0(0)(2)  
Comprehensive income (loss):62914312(4)2279
Comprehensive income, net of tax, attributable to noncontrolling interest    2 
Other undisclosed comprehensive income (loss), net of tax, attributable to parent1(1)  (0)6
Comprehensive income (loss), net of tax, attributable to parent:63014212(4)23014

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: